Literature DB >> 21391723

A synthetic GFP-like chromophore undergoes base-catalyzed autoxidation into acylimine red form.

Pavel E Ivashkin1, Konstantin A Lukyanov, Sergey Lukyanov, Ilia V Yampolsky.   

Abstract

Fluorescent proteins are widely used in modern experimental biology, but much controversy exists regarding details of maturation of different types of their chromophores. Here we studied possible mechanisms of DsRed-type red chromophore formation using synthetic biomimetic GFP-like chromophores, bearing an acylamino substituent, corresponding to an amino acid residue at position 65. We have shown these model compounds to readily react with molecular oxygen to produce a highly unstable DsRed-like acylimine, isolated in the form of stable derivatives. Under the same aerobic conditions an unusual red-shifted imide chromophore--a product of 4-electron oxidation of Gly65 residue--is formed. Our data showed that GFP chromophore is prone to autoxidation at position 65 Cα by its chemical nature with basic conditions being the only key factor required.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21391723     DOI: 10.1021/jo200150b

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

Review 1.  Chromophore transformations in red fluorescent proteins.

Authors:  Fedor V Subach; Vladislav V Verkhusha
Journal:  Chem Rev       Date:  2012-05-04       Impact factor: 60.622

2.  Genetically encoded calcium indicators for multi-color neural activity imaging and combination with optogenetics.

Authors:  Jasper Akerboom; Nicole Carreras Calderón; Lin Tian; Sebastian Wabnig; Matthias Prigge; Johan Tolö; Andrew Gordus; Michael B Orger; Kristen E Severi; John J Macklin; Ronak Patel; Stefan R Pulver; Trevor J Wardill; Elisabeth Fischer; Christina Schüler; Tsai-Wen Chen; Karen S Sarkisyan; Jonathan S Marvin; Cornelia I Bargmann; Douglas S Kim; Sebastian Kügler; Leon Lagnado; Peter Hegemann; Alexander Gottschalk; Eric R Schreiter; Loren L Looger
Journal:  Front Mol Neurosci       Date:  2013-03-04       Impact factor: 5.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.